Clinical Trial Update: Randomized Single-Blinded Study to Evaluate Safety and Immunogenicity of Recombinant Plague Vaccine With and Without Adjuvant [Phase 2]

View source ↗

Summary

Phase 2 randomized single-blinded trial evaluating safety and immunogenicity of a recombinant plague vaccine with and without an adjuvant.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plague

Drugs mentioned

• Recombinant Plague Vaccine

Snippet

Sponsor: DynPort Vaccine Company LLC, A GDIT Company | Conditions: Plague Vaccine | Phase 2 | Status: COMPLETED